Literature DB >> 11459061

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.

G P Saborio1, B Permanne, C Soto.   

Abstract

Prions are the infectious agents responsible for transmissible spongiform encephalopathies. The principal component of prions is the glycoprotein PrP(Sc), which is a conformationally modified isoform of a normal cell-surface protein called PrP(C) (ref. 1). During the time between infection and the appearance of the clinical symptoms, minute amounts of PrP(Sc) replicate by conversion of host PrP(C), generating large amounts of PrP(Sc) aggregates in the brains of diseased individuals. We aimed to reproduce this event in vitro. Here we report a procedure involving cyclic amplification of protein misfolding that allows a rapid conversion of large excess PrP(C) into a protease-resistant, PrP(Sc)-like form in the presence of minute quantities of PrP(Sc) template. In this procedure, conceptually analogous to polymerase chain reaction cycling, aggregates formed when PrP(Sc) is incubated with PrP(C) are disrupted by sonication to generate multiple smaller units for the continued formation of new PrP(Sc). After cyclic amplification more than 97% of the protease-resistant PrP present in the sample corresponds to newly converted protein. The method could be applied to diagnose the presence of currently undetectable prion infectious agent in tissues and biological fluids, and may provide a unique opportunity to determine whether PrP(Sc) replication results in the generation of infectivity in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459061     DOI: 10.1038/35081095

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  417 in total

1.  Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion.

Authors:  S M Uptain; G J Sawicki; B Caughey; S Lindquist
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  More on BSE/vCJD.

Authors:  A J Beale
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

3.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

4.  Disease-associated prion protein in vessel walls.

Authors:  Oskar Koperek; Gábor G Kovács; Diane Ritchie; James W Ironside; Herbert Budka; Georg Wick
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

5.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

6.  Progress toward an ultimate proof of the prion hypothesis.

Authors:  Susan W Liebman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

Review 7.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

9.  Methods of Protein Misfolding Cyclic Amplification.

Authors:  Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  Methods Mol Biol       Date:  2017

Review 10.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.